DUSP14 Antibody (N-term) Blocking Peptide

Catalog Number: ABT-BP8456A
Article Name: DUSP14 Antibody (N-term) Blocking Peptide
Biozol Catalog Number: ABT-BP8456A
Supplier Catalog Number: BP8456a
Alternative Catalog Number: ABT-BP8456A-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Dual specificity protein phosphatase 14, MKP-1-like protein tyrosine phosphatase, MKP-L, Mitogen-activated protein kinase phosphatase 6, MAP kinase phosphatase 6, MKP-6, DUSP14, MKP6
DUSP14 is involved in the inactivation of MAP kinases. This protein dephosphorylates ERK, JNK and p38 MAP-kinases. In addition to antigen recognition by the T-cell receptor, T-cell activation requires a second signal from a costimulatory receptor, such as CD28, which interacts with B7-1 and B7-2 ligands on antigen-presenting cells. CD28 costimulation induces transcription of interleukin-2 and stabilizes newly synthesized IL2 through the activation of mitogen-activated protein kinases (MAPKs), such as ERK and JNK, and the subsequent creation of AP1 transcription factor. DUSP14 is a negative regulator of CD28 signaling.
NCBI: 11072
UniProt: O95147
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP8456a was selected from the N-term region of human DUSP14. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.